| 7.04 -0.09 (-1.26%) | 12-31 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 8.41 | 1-year : | 9.83 |
| Resists | First : | 7.2 | Second : | 8.41 |
| Pivot price | 6.98  |
|||
| Supports | First : | 6.61 | Second : | 6.25 |
| MAs | MA(5) : | 7.1 |
MA(20) : | 6.84 |
| MA(100) : | 5.78 |
MA(250) : | 0 | |
| MACD | MACD : | 0.2 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 86.7 |
D(3) : | 91.3 |
| RSI | RSI(14): 67.7 |
|||
| 52-week | High : | 8.29 | Low : | 3.74 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ LFST ] has closed below upper band by 38.4%. Bollinger Bands are 53.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 7.2 - 7.24 | 7.24 - 7.27 |
| Low: | 6.92 - 6.95 | 6.95 - 6.99 |
| Close: | 6.98 - 7.04 | 7.04 - 7.09 |
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.
Tue, 23 Dec 2025
LifeStance Health Group (NASDAQ:LFST) Director Sells $11,975.04 in Stock - MarketBeat
Tue, 23 Dec 2025
LifeStance Health Group (NASDAQ:LFST) Director Robert Bessler Sells 119,942 Shares - MarketBeat
Mon, 22 Dec 2025
2026 Medical Utilization Forecasts Support BTIG’s Bullish View on LifeStance (LFST) - Yahoo Finance
Fri, 19 Dec 2025
Ann Varanakis Sells 50,000 Shares of LifeStance Health Group (NASDAQ:LFST) Stock - MarketBeat
Fri, 19 Dec 2025
Robert Bessler Sells 6,442 Shares of LifeStance Health Group (NASDAQ:LFST) Stock - MarketBeat
Sat, 13 Dec 2025
LifeStance Health Group (LFST): Assessing Valuation After a Recent Share Price Rebound - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 389 (M) |
| Shares Float | 165 (M) |
| Held by Insiders | 4.1 (%) |
| Held by Institutions | 94 (%) |
| Shares Short | 8,130 (K) |
| Shares Short P.Month | 6,980 (K) |
| EPS | -0.03 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.83 |
| Profit Margin | -0.7 % |
| Operating Margin | 2 % |
| Return on Assets (ttm) | 0.2 % |
| Return on Equity (ttm) | -0.7 % |
| Qtrly Rev. Growth | 16.2 % |
| Gross Profit (p.s.) | 1.14 |
| Sales Per Share | 3.52 |
| EBITDA (p.s.) | 0.16 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 151 (M) |
| Levered Free Cash Flow | 124 (M) |
| PE Ratio | -234.67 |
| PEG Ratio | 0 |
| Price to Book value | 1.83 |
| Price to Sales | 1.99 |
| Price to Cash Flow | 18.14 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|